1Bogdanov AA Jr, Chen JW, Kang HW, et al. Magnetic resonance signal amplification probes[J]. Ernst Schering Res,2005(49) : 147.
2Moghimi SM, Hunter AC, Murray JC. Long-circulating and target-specific nanoparticles: theory to practice[J]. Pharmacol Rev,2001,53(2) :283.
3Xu XH, Brownlow WJ, Kyriacou SV et al. Real-time probing of membrane transport in living microbial cells using single nanoparticle optics and living cell imaging[J]. Biochemistry,2004,43(32) : 10400.
4Petricoin EF, Rajapaske V, Herman EH, et al. Toxicoproteomics: serum proteomic pattern diagnostics for early detection of drug-induced cardiac toxicities and cardioprotection [J].Toxlcol Pathol, 2004, 32 ( Suppl. 1 ) : 122.
5Morawski AM, Winter PM, Crowder KC, et al. Targeted nanoparticles for quantitative imaging of sparse molecular epitopes with MRI[J]. Magn Reson Med,2004,51(3) :480.
6Harris JM, Chess RB. Effect of pegylation on pharmaceuticals [J]. Nat Rev Drug Discov,2003,2(3) :214.
7Gao X, Cui Y,Levenson RM,et al. In vivo cancer targeting and imaging with semiconductor quantum dots[J]. Nat Biotechnol,2004,22(8) :969.
8Moghimi SM, Szebeni J. Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties[J]. Prog Lipid Res,2003,42(6) :463.
9Kreuter J. Influence of the surface properties on nanoparticle-mediated transport of drugs to the brain [J] .J Nanosci Nanotechnol,2034,4(5) : 484.
10Nigavekar SS, Sung LY, Llanes M, et al. 3H dendrimer nanoparticle organ/tumor distribution [J] .Pharm Res,2004,21(3) : 476.
